19 results
10-K
2020 FY
EX-10.3
PTPI
Petros Pharmaceuticals Inc
31 Mar 21
Annual report
4:30pm
and on or prior to September 30, 2020, unrestricted (including not subject to any clawback, redemption, escrow or similar contractual restriction … not subject to any clawback, redemption, escrow or similar contractual restriction) net cash proceeds in an aggregate amount of at least $3,000,000, which
8-K
EX-10.2
PTPI
Petros Pharmaceuticals Inc
25 Feb 21
Departure of Directors or Certain Officers
4:15pm
supersede all prior and contemporaneous agreements and understandings, inducements or conditions, express or implied, oral or written.
14. Clawback … . In addition, the Option shall be subject to any applicable clawback or recoupment policies, share trading policies and other policies that may be implemented
10-K
2020 FY
EX-10.2
PTPI
Petros Pharmaceuticals Inc
31 Mar 21
Annual report
4:30pm
of the Additional Subordinated Indebtedness not subject to any redemption, clawback, escrow or similar encumbrance or restriction of any kind (it being
10-K
2020 FY
EX-10.4
PTPI
Petros Pharmaceuticals Inc
31 Mar 21
Annual report
4:30pm
(including not subject to any clawback, redemption, escrow or similar contractual restriction) net cash proceeds in an aggregate amount of at least
S-8
EX-99.1
8xwdvs
22 Dec 22
Registration of securities for employees
5:03pm
DEF 14A
rg1v2hxu9v yuy6
22 Nov 21
Definitive proxy
4:37pm
424B3
y65ibiahq 2c35xg22q9
14 Jan 22
Prospectus supplement
5:18pm
S-4/A
si6ho ryrn44xie
30 Sep 20
Registration of securities issued in business combination transactions (amended)
9:21am
S-4
7jwf6kmjw9sbg
24 Jul 20
Registration of securities issued in business combination transactions
12:00am
424B3
hxhtdgxug 86dkiav
2 Nov 20
Prospectus supplement
12:00am
- Prev
- 1
- Next